Literature DB >> 23707012

Type I collagen nerve conduits for median nerve repairs in the forearm.

Thomas Dienstknecht1, Silvan Klein, Jody Vykoukal, Sebastian Gehmert, Michael Koller, Martin Gosau, Lukas Prantl.   

Abstract

PURPOSE: To evaluate patients with median nerve damage in the distal forearm treated with type 1 collagen nerve conduits.
METHODS: Nine patients with damage to the median nerve in the distal forearm underwent treatment with a type 1 collagen nerve conduit. The nerve gaps ranged between 1 and 2 cm. An independent observer reexamined patients after treatment at a minimal follow-up of 14 months and a mean follow-up of 21 months. Residual pain was evaluated using a visual analog scale. Functional outcome was quantified by assessing static 2-point discrimination, nerve conduction velocity relative to the uninjured limb, and Disabilities of the Arm, Shoulder, and Hand outcome measure scoring. We also recorded quality of life measures including patients' perceived satisfaction with the results and return to work latency.
RESULTS: We observed no implant-related complications. Of 9 patients, 7 were free of pain, and the mean visual analog scale was 0.6. The mean Disabilities of the Arm, Shoulder, and Hand score was 6. The static 2-point discrimination was less than 6 mm in 3 patients, between 6 and 10 mm in 4 patients, and over 10 mm in 2 patients. Six patients reached a status of M4 or higher. Eight patients were satisfied with the procedure and would undergo surgery again.
CONCLUSIONS: This study indicates that purified type 1 bovine collagen conduits are a practical and efficacious method for the repair of median nerves in the distal forearm. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Copyright © 2013 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707012     DOI: 10.1016/j.jhsa.2013.03.028

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  9 in total

1.  Management of Iatrogenic Ulnar Nerve Transection.

Authors:  Mark Henry
Journal:  J Hand Microsurg       Date:  2014-06-08

Review 2.  Clinical outcomes for Conduits and Scaffolds in peripheral nerve repair.

Authors:  David J Gerth; Jun Tashiro; Seth R Thaller
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

Review 3.  Nerve Repair with Nerve Conduits: Problems, Solutions, and Future Directions.

Authors:  Ryan Rebowe; Ashley Rogers; Xuebin Yang; S C Kundu; Thomas L Smith; Zhongyu Li
Journal:  J Hand Microsurg       Date:  2018-03-20

Review 4.  Overcoming short gaps in peripheral nerve repair: conduits and human acellular nerve allograft.

Authors:  Jonathan Isaacs; Timothy Browne
Journal:  Hand (N Y)       Date:  2014-06

5.  Effects of carbon nanotubes in a chitosan/collagen-based composite on mouse fibroblast cell proliferation.

Authors:  Wen Zhao; Wenwen Yu; Jiawei Zheng; Ying Wang; Zhiyuan Zhang; Dongsheng Zhang
Journal:  Cell Mol Neurobiol       Date:  2013-09-20       Impact factor: 5.046

6.  Collagen Type I Conduits for the Regeneration of Nerve Defects.

Authors:  Silvan Klein; Jody Vykoukal; Oliver Felthaus; Thomas Dienstknecht; Lukas Prantl
Journal:  Materials (Basel)       Date:  2016-03-23       Impact factor: 3.623

7.  Differential Effects of Coating Materials on Viability and Migration of Schwann Cells.

Authors:  Silvan Klein; Lukas Prantl; Jody Vykoukal; Markus Loibl; Oliver Felthaus
Journal:  Materials (Basel)       Date:  2016-03-03       Impact factor: 3.623

Review 8.  Machine intelligence for nerve conduit design and production.

Authors:  Caleb E Stewart; Chin Fung Kelvin Kan; Brody R Stewart; Henry W Sanicola; Jangwook P Jung; Olawale A R Sulaiman; Dadong Wang
Journal:  J Biol Eng       Date:  2020-09-09       Impact factor: 4.355

9.  Type I collagen as an extracellular matrix for the in vitro growth of human small intestinal epithelium.

Authors:  Ziyad Jabaji; Garrett J Brinkley; Hassan A Khalil; Connie M Sears; Nan Ye Lei; Michael Lewis; Matthias Stelzner; Martín G Martín; James C Y Dunn
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.